Nanalysis Scientific Corp.
OTC:NSCIF
0.3189 (USD) • At close November 15, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 1.376 | 0.759 | 3.525 | 10.405 | 3.158 | 6.619 | 0.779 | 0.686 | 0.072 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.419 | 0.35 |
| Cash and Short Term Investments
| 1.376 | 0.759 | 3.525 | 10.405 | 3.158 | 6.619 | 0.779 | 1.105 | 0.422 |
| Net Receivables
| 11.066 | 9.758 | 7.138 | 6.1 | 3.045 | 2.561 | 4.011 | 1.553 | 0.83 |
| Inventory
| 4.386 | 5.794 | 7.387 | 3.679 | 2.83 | 0.857 | 0.735 | 0.673 | 1.015 |
| Other Current Assets
| 1.43 | 1.603 | 3.905 | 1.706 | 1.524 | 1.074 | 1.626 | 1.401 | 0.732 |
| Total Current Assets
| 18.258 | 17.914 | 21.955 | 20.762 | 9.352 | 10.165 | 5.559 | 4.732 | 2.998 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 2.893 | 4.737 | 6.424 | 2.539 | 1.95 | 1.634 | 1.136 | 0.624 | 0.665 |
| Goodwill
| 5.696 | 5.696 | 13.083 | 0.385 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 13.046 | 3.362 | 26.627 | 14.107 | 12.687 | 6.487 | 4.233 | 0.38 | 0.344 |
| Goodwill and Intangible Assets
| 18.742 | 9.058 | 39.71 | 14.492 | 12.687 | 6.487 | 4.233 | 0.38 | 0.344 |
| Long Term Investments
| 0 | 5.727 | 0.77 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0.104 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 2.478 | 16.388 | 0.939 | 0 | 0 | 0.02 | 0.02 | 2.535 | 2.196 |
| Total Non-Current Assets
| 24.113 | 35.91 | 47.947 | 17.031 | 14.637 | 8.141 | 5.389 | 3.539 | 3.205 |
| Total Assets
| 42.371 | 53.824 | 69.902 | 37.793 | 23.989 | 18.306 | 10.948 | 0.691 | 0.079 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 5.826 | 5.081 | 5.759 | 4.441 | 2.619 | 0.678 | 1.03 | 1.154 | 0.861 |
| Short Term Debt
| 6.841 | 7.286 | 4.44 | 2.198 | 0.434 | 0.248 | 0.233 | 0.646 | 0.489 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 1.193 | 0 | 1.932 | 1.798 | 2.2 | 0.616 | 0.316 | 0 | 0 |
| Other Current Liabilities
| 0.517 | 2.229 | 1.375 | 0.209 | 1.718 | 0.089 | 0.178 | 0.386 | -1.346 |
| Total Current Liabilities
| 14.377 | 14.596 | 13.506 | 8.646 | 6.303 | 1.631 | 1.757 | 2.186 | 0.004 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 11.52 | 14.682 | 6.313 | 3.787 | 3.342 | 1.259 | 0.764 | 0.858 | 0.882 |
| Deferred Revenue Non-Current
| 0.653 | 0 | 1.117 | 0.822 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0.117 | 0.184 | 0.256 | 0.258 | 0 | 0.297 | 0.036 | 0 | 0 |
| Other Non-Current Liabilities
| 0.158 | 0.881 | 2.255 | 1.141 | 0.668 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 12.448 | 15.747 | 8.824 | 5.186 | 4.01 | 1.556 | 0.8 | 0.858 | 0.882 |
| Total Liabilities
| 26.825 | 30.343 | 22.33 | 13.832 | 9.645 | 3.187 | 2.557 | 0.059 | 0.004 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 57.565 | 53.201 | 49.016 | 31.295 | 20.665 | 18.267 | 9.976 | 0.761 | 6.774 |
| Retained Earnings
| -48.602 | -34.989 | -18.793 | -9.692 | -7.92 | -4.242 | -2.582 | -0.197 | -0.025 |
| Accumulated Other Comprehensive Income/Loss
| 0.43 | 0.238 | 0.969 | 0.714 | 0.215 | 0 | -0 | 0.067 | 0.715 |
| Other Total Stockholders Equity
| 6.153 | 4.673 | 3.938 | 1.644 | 1.384 | 1.094 | 0.997 | 0 | -7.389 |
| Total Shareholders Equity
| 15.546 | 23.481 | 35.13 | 23.961 | 14.344 | 15.119 | 8.391 | 0.631 | 0.075 |
| Total Equity
| 15.546 | 23.481 | 47.572 | 23.961 | 14.344 | 15.119 | 8.391 | 0.631 | 0.075 |
| Total Liabilities & Shareholders Equity
| 42.371 | 53.824 | 69.902 | 37.793 | 23.989 | 18.306 | 10.948 | 0.691 | 0.079 |